作者：
Elizabeth K,Lee [1]
;
Niya,Xiong [2]
;
Su-Chun,Cheng [2]
;
William T,Barry [2]
;
Richard T,Penson [3]
;
Panagiotis A,Konstantinopoulos [4]
;
Mark A,Hoffman [5]
;
Neil,Horowitz [6]
;
Don S,Dizon [7]
;
Elizabeth H,Stover [4]
;
Alexi A,Wright [4]
;
Susana M,Campos [4]
;
Carolyn,Krasner [3]
;
Stephanie,Morrissey [8]
;
Christin,Whalen [8]
;
Roxanne,Quinn [8]
;
Ursula A,Matulonis [9]
;
Joyce F,Liu [10]
作者单位：
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
[1]
Department of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, United States of America.
[2]
Department of Medical Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, United States of America.
[3]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
[4]
Long Island Jewish Medical Center, New Hyde Park, NY, United States of America.
[5]
Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Obstetrics & Gynecology, Brigham & Women's Hospital, Boston, MA, United States of America.
[6]
Brown University, Division of Women's Cancers, Lifespan Cancer Institute, Providence, RI, United States of America.
[7]
Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
[8]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America. Electronic address: Ursula_Matulonis@dfci.harvard.edu.
[9]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America. Electronic address: Joyce_Liu@dfci.harvard.edu.
[10]
DOI
10.1016/j.ygyno.2020.07.028
PMID
32771276
发布时间
2021-04-14
换一批
换一批
